Reduce portion sizes or swap higher-calorie items for lower-calorie ones
Generally, individuals with a body mass index (BMI) of 30 or higher or a BMI of 27 or higher with at least one weight-related health condition, such as type 2 diabetes, high blood pressure, or high cholesterol, may qualify for Semaglutide GLP-1 treatment
Semaglutide brands like Wegovy, Ozempic, and oral Rybelsus appear in obesity and type 2 diabetes trials
Beyond calories, alcohol can also lower inhibitions around food choices, disrupt sleep, and interact with how your body processes fat
For patients considering GLP-1 therapy while on antihypertensives, understanding the interaction mechanisms and your individual metabolic profile is crucial
By activating these receptors, GLP-1 agonists enhance insulin secretion when blood sugar levels are high, helping to lower blood sugar levels